• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Responses After Community Infections in Children and

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2023 Mar 28;10(5):ofad168.
doi: 10.1093/ofid/ofad168. eCollection 2023 May. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Responses After Community Infections in Children and Adults

Fatimah S Dawood[SUP] 1 [/SUP], Alexia Couture[SUP] 1 [/SUP], Xueyan Zhang[SUP] 2 [/SUP], Melissa S Stockwell[SUP] 3 4 [/SUP], Christina A Porucznik[SUP] 5 [/SUP], Joseph B Stanford[SUP] 5 [/SUP], Marissa Hetrich[SUP] 2 [/SUP], Vic Veguilla[SUP] 1 [/SUP], Natalie Thornburg[SUP] 1 [/SUP], Christopher D Heaney[SUP] 2 [/SUP], Jing Wang[SUP] 1 [/SUP], Jazmin Duque[SUP] 6 [/SUP], Zuha Jeddy[SUP] 6 [/SUP], Maria Deloria Knoll[SUP] 2 [/SUP], Ruth Karron[SUP] 2 [/SUP]



Affiliations
Abstract

Background: We compared postinfection severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (nAb) responses among children and adults while the D614G-like strain and Alpha, Iota, and Delta variants circulated.
Methods: During August 2020-October 2021, households with adults and children were enrolled and followed in Utah, New York City, and Maryland. Participants collected weekly respiratory swabs that were tested for SARS-CoV-2 and had sera collected during enrollment and follow-up. Sera were tested for SARS-CoV-2 nAb by pseudovirus assay. Postinfection titers were characterized with biexponential decay models.
Results: Eighty participants had SARS-CoV-2 infection during the study (47 with D614G-like virus, 17 with B.1.1.7, and 8 each with B.1.617.2 and B.1.526 virus). Homologous nAb geometric mean titers (GMTs) trended higher in adults (GMT = 2320) versus children 0-4 (GMT = 425, P = .33) and 5-17 years (GMT = 396, P = .31) at 1-5 weeks postinfection but were similar from 6 weeks. Timing of peak titers was similar by age. Results were consistent when participants with self-reported infection before enrollment were included (n = 178).
Conclusions: The SARS-CoV-2 nAb titers differed in children compared to adults early after infection but were similar by 6 weeks postinfection. If postvaccination nAb kinetics have similar trends, vaccine immunobridging studies may need to compare nAb responses in adults and children 6 weeks or more after vaccination.

Keywords: SARS-CoV-2; adults; antibodies; children.

 
Back
Top Bottom